Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a naturally occurring non-protein-coding antisense RNA transcribed from the strand opposite the DCT (dopachrome tautomerase) gene. Natural antisense transcripts are widespread in eukaryotic genomes and often regulate sense gene expression through various mechanisms, including chromatin remodeling, modulation of sense transcript stability, interference with transcription, or participation in epigenetic modification. The vast majority of natural antisense transcripts, including this one, remain poorly characterized, and most do not have well-established functions or clinical relevance. There is currently no evidence to support a direct role of this specific antisense transcript in disease, and no approved therapeutics, biomarkers, or drug interactions are associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to DCT.